1. Jones A, Jarvis P. Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury. Clin Exp Emerg Med. 2017 Sep 30;4(3):121-127. doi: 10.15441/ceem.17.226. PMID: 29026884; PMCID: PMC5635461.
2. O'Neil ME, Carlson K, Storzbach D, et al. Complications of Mild Traumatic Brain Injury in Veterans and Military Personnel: A Systematic Review [Internet]. Washington (DC): Department of Veterans Affairs (US); 2013 Jan.
3. Agoston DV, Shutes-David A, Peskind ER. Biofluid biomarkers of traumatic brain injury. Brain Inj. 2017;31(9):1195-1203. doi: 10.1080/02699052.2017.1357836. PMID: 28981341.
4. Borg K, Bonomo J, Jauch EC, et al. Serum Levels of Biochemical Markers of Traumatic Brain Injury. ISRN Emerg. Med. 2012;2012:1–7. https://www.hindawi.com/journals/isrn/2012/417313
5. Yokobori S, Hosein K, Burks S, et al. Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review. CNS Neurosci Ther. 2013 Aug;19(8):556-65. doi: 10.1111/cns.12127.
6. Sapin V, Gaulmin R, Aubin R, et al. Blood biomarkers of mild traumatic brain injury: State of art. Neurochirurgie. 2021 May;67(3):249-254. doi: 10.1016/j.neuchi.2021.01.001.
7. Welch RD, Ayaz SI, Lewis LM, et al. Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neu- rotrauma 2016;33(2):203–14.
8. Unden L, Calcagnile O, Unden J, et al. Validation of the Scan- dinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults. BMC Med 2015;13:292
9. Kawata K, Liu CY, Merkel SF, et al. Blood biomarkers for brain injury: What are we measuring? Neurosci Biobehav Rev. 2016 Sep; 68: 460–473. doi: 10.1016/j.neubiorev.2016.05.009
10. Michetti F, D'Ambrosi N, Toesca A, et al. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019 Jan;148(2):168-187. doi: 10.1111/jnc.14574.
11. Hiskens MI, Schneiders AG, Angoa-Pérez M,et al. Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy. Biomarkers. 2020 May;25(3):213-227. doi: 10.1080/1354750X.2020.1735521.
12. Berger RP, Hayes RL, Richichi R, et al. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and alphaII-spectrin breakdown product 145kDa correlate with outcome after pediatric TBI. J Neurotrauma 2012;29(1):162–7.
13. Venkatramani A, Panda D. Regulation of neuronal microtubule dynamics by tau: implications for tauopathies. Int J Biol Macromol 2019;133:473–83.
14. Cardali S, Maugeri R. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J Neurosurg Sci. 2006 Jun;50(2):25-31. PMID: 16841024.
15. Zemlan FP, Jauch EC, Mulchahey JJ, et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 2002 Aug 23;947(1):131-9. doi: 10.1016/s0006-8993(02)02920-7. PMID: 12144861.
16. Papa L, Lewis LM, Silvestri S, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg. 2012 May;72(5):1335-44. doi: 10.1097/TA.0b013e3182491e3d. PMID: 22673263; PMCID: PMC5516044.
17. Papa, L, et al. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. JAMA Neurol. 2016;73(5): 551-560
18. Wąsik N, Sokół B, Hołysz M, et al. Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2020 Mar;162(3):545-552. doi: 10.1007/s00701-019-04185-9.
19. Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016 Oct;12(10):563-74. doi: 10.1038/nrneurol.2016.127.
20. Rubin LH, Tierney R, Kawata K, et al. NFL blood levels are moderated by subconcussive impacts in a cohort of college football players. Brain Inj. 2019;33(4):456-462. doi: 10.1080/02699052.2019.1565895.
21. Bogoslovsky T, Gill J, Jeromin A, et al. Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use. Diagnostics (Basel). 2016 Oct 18;6(4):37. doi: 10.3390/diagnostics6040037.
22. Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. doi: 10.1080/14737159.2018.1428089.
23. Gan ZS, Stein SC, Swanson R, et al. Blood Biomarkers for Traumatic Brain Injury: A Quantitative Assessment of Diagnostic and Prognostic Accuracy. Front Neurol. 2019 Apr 26;10:446. doi: 10.3389/fneur.2019.00446.
Facebook 
Masuk dengan Email
